The Hedgehog (Hh) pathway is an evolutionarily conserved signaling mechanism that allows graded responses from cells and tissues to control fundamental biological processes such as cell fate specification, tissue patterning, regulation of proliferation, and maintenance of tissue homeostasis for developing and adult organisms. Hh pathway activation is also essential for proper development of the skin and its appendages, where overactivation of the pathway can lead to hyperproliferation of the epidermis, defects in differentiation, and cancer (Adolphe et al., 2014; Atwood et al., 2014) . However, the relationship between levels of Hh pathway activation and tissue development and disease is unclear, because precise quantitative measurements are lacking.
Patched1 (Ptch1) and, to a lesser extent, patched2 (Ptch2) are transmembrane receptors that act to inhibit Hh pathway activation in vertebrates. Ptch1 acts by keeping the G-protein coupled receptor Smoothened out of the primary cilium, which prevents the Gli transcription factors (Gli1 and Gli2) from entering the nucleus. On Hh ligand binding to Ptch1, Smoothened relocalizes to the primary cilium, allowing the Gli proteins to enter the nucleus and activate Hh target genes that include Ptch1 and Gli1. As the Ptch1 transcript is upregulated, newly formed Ptch1 protein binds and internalizes available Hh ligand, thus attenuating Hh signaling events. Mutations that inactivate Ptch1, or activate Smoothened, lead to constitutive Hh pathway activation that is able to initiate and drive the growth of select cancers, including basal cell carcinoma (BCC) (Atwood et al., 2014) . Ptch2 may act redundantly with Ptch1, but its role in Hh pathway regulation is yet to be fully elucidated.
Although both Ptch1 and Ptch2 are expressed in the developing hair follicle, Ptch1 seems to be the prominent regulator of Hh signaling, as the authors have shown previously that its removal is sufficient to drive hyperplastic growth, whereas loss of Ptch2 does not (Adolphe et al., 2014) . Concomitant loss of Ptch1 and Ptch2 leads to more severe neoplasias, with features resembling human BCCs. Although multiple investigative groups suggest that the severity of phenotypes observed in skin with constitutively active Hh signaling depends on Hh activation levels, precise spatiotemporal quantitative measurements are lacking (Epstein, 2011; Grachtchouk et al., 2003) . Adolphe et al. (2017) extend their own work by precisely quantifying Hh transcript levels of wild-type, Ptch1-deficient, and Ptch1;Ptch2-deficient skin using single molecule RNA fluorescent in situ hybridization (smFISH), and they have found a gradient of Hh pathway activation that may specify hair follicle progenitor cells and BCC growth.
smFISH quantifies Hh signaling levels at precise locations within mouse skin smFISH uses fluorescently labeled oligonucleotide probes, combined with fluorescent microscopy, to visualize individual mRNA molecules (Femino et al., 1998) . This technique allows for precise counts of transcripts within single cells, an important issue as appreciation of cellular heterogeneity within a tissue grows. Another advantage of smFISH is the quantification of transcripts at their precise cellular localization, which gives information on when and where a protein is translated to potentially create signaling gradients and restrict protein function to exact cellular locations (Crosetto et al., 2015) . Adolphe et al. (2017) -deficient skin was observed, consistent with the authors' previous work demonstrating that Ptch2 is only required to attenuate Hh signaling levels in Ptch1-deficient tissue, suggesting a role for Ptch2 in limiting tumor growth (Adolphe et al., 2014) .
When taking a closer look at the developing hair follicle, the authors are able to quantitate a proximal-distal gradient of Hh pathway activation reminiscent of Hh signaling gradients within vertebrate neural tubes. They define three distinct levels of Hh activation with the peak zone in the hair follicle bulge, which is closest to the source of Hh ligand from the dermal papillae and secondary hair germ, an intermediate level in the upper bulge and isthmus, and lowest levels near the sebaceous gland and in the infundibulum, which resembles levels in the interfollicular epidermis (Figure 1) . Interestingly, levels observed in the intermediate zone were similar to those observed in Ptch1-deficient interfollicular epidermis, and the peak zone levels were similar to Ptch1;Ptch2-deficient skin. Ptch1;Ptch2-deficient skin likely represents the highest level of Hh signaling due to the complete lack of negative pathway regulation.
Does Hedgehog specify hair follicle lineages?
Spatial regulation of Hh signaling is essential for the developing vertebrate neural tube. A dorsal-ventral Hh gradient within the neural tube defines six molecularly distinct neuronal domains, with highest Hh levels present at the ventral side near the source of Hh ligand from the notochord and floor plate. Each of the domains gives rise to well-defined progenitor subtypes that populate the central nervous system with all the necessary neuronal types. Hh accomplishes this by activating transcription factors Dbx1, Dbx2, Foxa2, Nkx2.2, and Olig2, while repressing Lrx3, Pax6, and Pax7 in a graded fashion to generate a transcription code within each domain (Dessaud et al., 2008) .
Intriguingly, hair follicles also have multiple distinct stem cell compartments that express lineage-specific markers and transcription factors in a spatiotemporal pattern within the developing and adult hair follicle (Woo and Oro, 2011) . Lgr5, Gli1, and K15 are lineage markers in the lower bulge; NFATc1, Sox9, Lhx2, Tcf3, and CD34 are markers in the upper bulge; Lgr6 and Mts24 are markers in the isthmus; and Lrig1, Prdm1, and Dlx3 are markers in the infundibulum. The authors have previously shown that loss of Ptch1;Ptch2 in developing hair follicles using a K14 promoter arrests hair follicles at the hair germ stage. They contain no discernable dermal papillae or isthmus/infundibulum (Adolphe et al., 2014) , suggesting a critical role for a graded Hh response to specify hair follicle progenitor subtypes. Whether a gradient in Hh response plays a role in defining molecularly distinct hair follicle progenitor domains has yet to be fully explored, but it is attractive to speculate that the transcription factors responsible for specifying the isthmus, sebaceous gland, and infundibulum require an Hh gradient to generate a skin-specific code that defines this structure.
Use of Hedgehog levels to predict tumor phenotype severity
Inappropriate activation of the Hh pathway drives initiation and progression of multiple cancer types, including BCC, making the pathway a
Clinical Implications
Single molecule fluorescent in situ hybridization may provide a useful diagnostic tool to differentiate among benign, drug-sensitive, and drug-resistant Hedgehog-driven tumors. -deficient skin displays only peak Hh activation throughout developmentally delayed hair follicles and hyperproliferative skin. Hh, Hedgehog; Ptch, patched. robust target for therapeutics. Although quite effective, Hh pathway inhibitors display a high innate and acquired resistance rate in later stage tumors (Atwood et al., 2014) . Even early stage tumors may contain drug-resistant clones as BCCs display the highest mutation rate out of all sequenced cancers (Atwood et al., 2015) , suggesting that a diagnostic tool that would differentiate among benign, drug-sensitive, and drug-resistant tumors would be beneficial to patients. Interestingly, drug-resistant tumors consistently display higher Hh activation levels than drug-sensitive tumors (Atwood et al., 2015) . In addition, other Hh-mediated conditions such as benign basaloid follicular hamartomas, which resemble BCCs but are typically indolent and innocuous (Grachtchouk et al., 2003) , may fall along a continuum of Hh activation that a smFISH diagnostic may be able to distinguish clinically to help determine the proper therapeutic approach.
